A Phase I Study of Hypofractionated Preoperative Radiation for Head and Neck Cancers (HyPR-HN)

Protocol No
IIT-ZENGA-HYPR-HN
Principal Investigator
Joseph Zenga
Phase
I
Summary
In this study, we want to find out whether the reduction of the radiation treatment fractions (to 10, 7, or 5 instead of 30) with a higher dose per fraction may be delivered in resected Head and Neck Squamous Cell Carcinoma patients.
Description
In this study, we want to find out whether the reduction of the radiation treatment fractions (to 10, 7, or 5 instead of 30) with a higher dose per fraction may be delivered in resected Head and Neck Squamous Cell Carcinoma patients.
Participating Institutions
Froedtert Hospital
Status
RESEARCH MANAGER-DTL SIGNOFF
Sub Category